Evidence map›Paper›PMID 33744866›Full record

ArticleAging2021

lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis.

Zhongyi Zhou, Fengbo Tan, Qian Pei, Chenglong Li, Yuan Zhou, Yuqiang Li, Haiping Pei

Open access · greenAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Long Non-Coding RNAGenes · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhongyi ZhouDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Fengbo TanDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Qian PeiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Chenglong LiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Yuan ZhouDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Yuqiang LiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Haiping PeiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a prevalent malignancy worldwide. The development of genome sequencing technology has allowed the discovery that epigenetic regulation might play a critical role in CRC tumorigenesis. In the present study, we found that the long noncoding RNA (lncRNA) SNHG4 was dramatically increased in CRC tissue samples and cell lines based on both publicly available and experimental data. SNHG4 knockdown suppressed the viability and colony formation capacity of CRC cells. The expression of CDK1 was considerably increased in CRC tissue samples and cells and had a positive correlation with the expression of SNHG4 in CRC. SNHG4 silencing not only caused S phase cell cycle arrest but also significantly downregulated the CDK1, cyclin B1, and cyclin A2 protein levels in CRC cells. miR-590-3p simultaneously bound to SNHG4 and CDK1. miR-590-3p functioned to inhibit CDK1 expression. miR-590-3p overexpression exerted the same effects on the CRC cell phenotype as SNHG4 knockdown. The effects of si-SNHG4 on CRC cells were significantly reversed by anti-miR-590-3p, indicating that SNHG4 relieved the miR-590-3p-induced inhibition of CDK1 by acting as a competing endogenous RNA (ceRNA).

Indexed as

CDC2 Protein KinaseCell CycleCell Line, TumorCell ProliferationCell Transformation, NeoplasticColorectal NeoplasmsGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMicroRNAsRNA, Long NoncodingSignal TransductionCDC2 Protein KinaseMicroRNAsRNA, Long NoncodingCDK1cell cyclecolorectal cancer (CRC)lncRNA SNHG4miR-590-3p

Identifiers

PMID33744866
PMCPMC8064176
OpenAlexW3138085974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.